ConductScience.org, home

Paper29909151

Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources.

Ishio T and 15 others. Biol Blood Marrow Transplant, 2018. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources. Papers, record 29909151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29909151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources.
PubMed
Journal
Biol Blood Marrow Transplant
PubMed
Year
2018
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2019-08-27
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishio TTakashi
2Sugita JJunichi
3Tateno TTakahiro
4Hidaka DDaisuke
5Hayase EEiko
6Shiratori SSouichi
7Okada KKohei
8Goto HHideki
9Onozawa MMasahiro
10Nakagawa MMasao
11Hashimoto DDaigo
12Kahata KKaoru
13Fujimoto KKatsuya
14Endo TTomoyuki
15Kondo TTakeshi
16Teshima TTakanori

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematologic NeoplasmsMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Transplantation ConditioningMajor topic
Adolescent
Adult
Aged
Allografts
Cyclosporine
Disease-Free Survival
Female
Graft vs Host Disease
Humans
Male
Middle Aged
Predictive Value of Tests
Remission Induction
Retrospective Studies
Survival Rate
Tacrolimus

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
40981006Prolonged Hematogone Expansion Is Associated with Better Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Hematol Rep2025https://conductscience.org/library/papers/40981006PubMed
38651452
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience.
Hematol Rep2024https://conductscience.org/library/papers/38651452PubMed
38312180Analytical Appraisal of Hematogones in B-ALL MRD Assessment Using Multidimensional Dot-Plots by Multiparametric Flow Cytometry: A Critical Review and Update.Indian J Hematol Blood Transfus2024https://conductscience.org/library/papers/38312180PubMed
37987308Influence of Housing Temperature and Genetic Diversity on Allogeneic T Cell-Induced Tissue Damage in Mice.Pathophysiology2023https://conductscience.org/library/papers/37987308PubMed
37854480Prognostic Value of Hematogones in Patients With Hematopoietic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.Cureus2023https://conductscience.org/library/papers/37854480PubMed
37092551Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide.JCI Insight2023https://conductscience.org/library/papers/37092551PubMed
36258726Bone Marrow Grafts From Pediatric Donors May Contain A Considerable Number of Hematogones.Indian J Hematol Blood Transfus2022https://conductscience.org/library/papers/36258726PubMed
35479094CpG-Activated Regulatory B-Cell Progenitors Alleviate Murine Graft-Versus-Host-Disease.Front Immunol2022https://conductscience.org/library/papers/35479094PubMed
31871314The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease.Sci Rep2019https://conductscience.org/library/papers/31871314PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29909151

GET https://conductscience.org/api/papers/v1/29909151/authors